81 related articles for article (PubMed ID: 8538171)
1. Transforming growth factor-beta 1 serves as an autocrine inhibitor of human endothelial cell/lymphocyte adhesion.
Rhodes JM; Engelmyer E; Tilberg AF; Gifford RR
J Surg Res; 1995 Dec; 59(6):719-24. PubMed ID: 8538171
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta 1 and IL-4 regulate the adhesiveness of Peyer's patch high endothelial venule cells for lymphocytes.
Chin YH; Cai JP; Xu XM
J Immunol; 1992 Feb; 148(4):1106-12. PubMed ID: 1737929
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory effect of low-dose X-irradiation and the involvement of a TGF-beta1-induced down-regulation of leukocyte/endothelial cell adhesion.
Roedel F; Kley N; Beuscher HU; Hildebrandt G; Keilholz L; Kern P; Voll R; Herrmann M; Sauer R
Int J Radiat Biol; 2002 Aug; 78(8):711-9. PubMed ID: 12194755
[TBL] [Abstract][Full Text] [Related]
4. Evidence that TGF-beta can inhibit human T-lymphocyte proliferation through paracrine and autocrine mechanisms.
Fox FE; Ford HC; Douglas R; Cherian S; Nowell PC
Cell Immunol; 1993 Aug; 150(1):45-58. PubMed ID: 8393732
[TBL] [Abstract][Full Text] [Related]
5. Endothelial cell adhesiveness for human T lymphocytes is inhibited by transforming growth factor-beta 1.
Gamble JR; Vadas MA
J Immunol; 1991 Feb; 146(4):1149-54. PubMed ID: 1704031
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
Joyce NC; Harris DL; Mello DM
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
8. IL-3 affects endothelial cell-mediated smooth muscle cell recruitment by increasing TGF beta activity: potential role in tumor vessel stabilization.
Dentelli P; Rosso A; Calvi C; Ghiringhello B; Garbarino G; Camussi G; Pegoraro L; Brizzi MF
Oncogene; 2004 Mar; 23(9):1681-92. PubMed ID: 14755254
[TBL] [Abstract][Full Text] [Related]
9. Retinoids potentiate transforming growth factor-beta activity in bovine endothelial cells through up-regulating the expression of transforming growth factor-beta receptors.
Yoshizawa M; Miyazaki H; Kojima S
J Cell Physiol; 1998 Sep; 176(3):565-73. PubMed ID: 9699509
[TBL] [Abstract][Full Text] [Related]
10. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1.
Yamamoto T; Eckes B; Krieg T
Biochem Biophys Res Commun; 2001 Feb; 281(1):200-5. PubMed ID: 11178980
[TBL] [Abstract][Full Text] [Related]
11. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium.
Smith WB; Noack L; Khew-Goodall Y; Isenmann S; Vadas MA; Gamble JR
J Immunol; 1996 Jul; 157(1):360-8. PubMed ID: 8683138
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta.
Kim YS; Kim BC; Song CY; Hong HK; Moon KC; Lee HS
J Lab Clin Med; 2001 Jul; 138(1):59-68. PubMed ID: 11433229
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta 1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells.
Chen CC; Manning AM
Cytokine; 1996 Jan; 8(1):58-65. PubMed ID: 8742067
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta 2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo.
Fabry Z; Topham DJ; Fee D; Herlein J; Carlino JA; Hart MN; Sriram S
J Immunol; 1995 Jul; 155(1):325-32. PubMed ID: 7602108
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta is an endogenous radioresistance factor in the esophageal adenocarcinoma cell line OE-33.
Kim AH; Lebman DA; Dietz CM; Snyder SR; Eley KW; Chung TD
Int J Oncol; 2003 Dec; 23(6):1593-9. PubMed ID: 14612931
[TBL] [Abstract][Full Text] [Related]
18. Role of transforming growth factor-beta 1 on platelet-induced enhancement of endothelin-1 production in cultured vascular endothelial cells.
Murata S; Matsumura Y; Takada K; Asai Y; Takaoka M; Morimoto S
J Pharmacol Exp Ther; 1995 Sep; 274(3):1524-30. PubMed ID: 7562529
[TBL] [Abstract][Full Text] [Related]
19. The role of growth factors in peritoneal healing: transforming growth factor beta (TGF-beta).
Chegini N
Eur J Surg Suppl; 1997; (577):17-23. PubMed ID: 9076448
[TBL] [Abstract][Full Text] [Related]
20. Induction of transforming growth factor beta 1 by insulin-like growth factor-1 in dermal fibroblasts.
Ghahary A; Shen Q; Shen YJ; Scott PG; Tredget EE
J Cell Physiol; 1998 Mar; 174(3):301-9. PubMed ID: 9462692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
